Modified blalock-taussig shunt in palliative cardiac surgery by Ussiri, EV et al.
23 
 
East and Central African Journal of Surgery Volume 12 Number 2      November /December 2007 
 
Modified Blalock-Taussig Shunt in Palliative Cardiac Surgery 
 
E.V. Ussiri1, E.T.M. Nyawawa1, U. Mpoki2, E.R. Lugazia2, G.C. Mannam3, L.R. Sajja4.  S. Sompali4       
1Specialist Surgeon, Cardiothoracic Surgery,  2Cardiac Anaesthesiology & Critical Care, 3Chief 
Cardiothoracic Surgeon, 4Consultant Cardiothoracic Surgeon - CARE Hospital, Hyderabad-India. 
Correspondence to: Dr.Elijah V. Ussiri, E-mail: eussiri@yahoo.com 
Background: Cyanotic congenital heart diseases present early in life with poor general 
condition of the patient. Majority of deaths occurs within one year of life before surgical 
intervention due to severe cyanosis and metabolic acidosis. Modified Blalock-Taussig Shunt 
(MBTS) is one of the palliative cardiac surgeries done for cyanotic congenital heart diseases. 
It improves the general condition of the patient before definitive surgery is done. The aim of 
this study was to determine the commonest indications, post-operative anticoagulation and 
early complications following MBTS at CARE Hospital, India.                   
Methods: This was a retrospective study from January 2004 to December 2006 including all 
patients who underwent Posterolateral Thoracotomy for MBTS. All patients had deep 
cyanosis, oxygen saturation of 65% or less and small pulmonary vasculature due to 
congenital heart defects. Acyanotic patients and those with oxygen saturation more than 65% 
were excluded from the study. All patients received a single dose of heparin intra-operatively 
and oral aspirin as anticoagulant regimen post-operatively. No heparin given post-
operatively.                                                                                                                                
Results: A total of 20 children with a mean age of 27.4 months were studied. Two patients had 
pre-operative ICU admission due to severe cyanosis (both had oxygen saturation of 35%), 
hypotension and severe body weakness. The commonest indications for MBTS included 
Tetralogy of Fallot (70%), pulmonary atresia (10%) with or without Ventricular Septal 
Defect (VSD), tricuspid atresia (10%) with pulmonary atresia or stenosis and Double Outlet 
Right Ventricle (DOVR) with pulmonary atresia or stenosis (10%). Mean duration of ICU 
stay was 2 days, mean duration of mechanical ventilation was four and half hours, mean 
duration of hospital stay was 7 days and mean systemic oxygen saturation improved 
significantly from 46% to 84% ( x2 = 7.03, p = 0.0080). No post-operative bleeding, seroma, 
shunt thrombosis or death occurred in this study.                    
Conclusion: The commonest indication for MBTS is TOF. Intra-operative single dose of 
heparin followed by post-operative oral aspirin as anticoagulant regimen was not associated 
with a major complication in terms of bleeding, seroma, shunt thrombosis, or death. 
Introduction 
 
Modified Blalock-Taussig Shunt is a common 
palliative surgery done for cyanotic 
congenital heart diseases associated with 
reduced pulmonary blood flow prior to 
definitive surgery1,2. It is one of the systemic 
to pulmonary artery shunts whereby a 
synthetic conduit mainly 
Polytetrafluoroethylene - PTFE (Gore Tex) is 
anastomosed mainly between  right 
subclavian artery and right pulmonary artery 
or left side occasionally. Cyanotic children 
present with poor nutritional status, 
desaturation, metabolic acidosis and low 
cardiac output3,4. Haemodynamic and 
biochemical unstable patients require ICU 
admission for resuscitation and 
haemodynamic stabilization prior to MBTS5. 
The issue of post-operative heparin as 
anticoagulant to prevent shunt thrombosis has 
remained controversial as it differs from one 
center to another6,7. 
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MBTS significantly improve growth of main, 
left and right pulmonary arteries and 
pulmonary valve annulus due to improved 
pulmonary blood flow4.  
Consequently, these improve the general 
condition of the patient with good 
haemodynamic and biochemical status prior 
to definitive correction4,5. The commonest 
complications following MBTS include shunt 
thrombosis leading to obstruction, shunt 
stenosis, infection, peri-shunt (graft) seroma, 
pseudoaneurysm and pulmonary artery 
distortion2. This retrospective study was 
aimed at determining the indications, post-
operative anticoagulation and immediate 
complications following MBTS at Care 
Hospital, Hyderabad-India.  
Patients and Methods 
A retrospective study was undertaken from 
January2004 to December 2006. The study 
population included all patients who had 
Modified Blalock-Taussig Shunt (MBTS) at 
Care Hospital, India. The Theatre Register 
and Medical Records were used to obtain the 
necessary information from the patients’ files 
till the day of discharge from the hospital.  
MBTS was indicated for all patients with 
deep cyanosis, oxygen saturation of 65% or 
less and small pulmonary vasculature by 2D 
echocardiography. Acyanotic patients and 
those with oxygen saturation above 65% were 
planned for definitive (primary) correction 
and therefore excluded from this study. Two 
patients had pre-operative ICU admission due 
to severe cyanosis (both had oxygen 
saturation of 35%) and hypotension. They 
were stabilized by ventilation, hydration, 
cardiac support with inotropic and ductal 
dilatation with Prostaglandin E1 infusion 
(0.05 µg/kg/min). Surgical approach was 
through conventional postero-lateral 
thoracotomy. All patients received heparin, 1 
mg/kg intravenously stat just before shunt 
anastomosis. The size (diameter) of the shunt 
depends on the weight of the patient such 
that, neonate less than 2.0 kg = 3.0 mm 
diameter, infancy between 2.0 - 3.5 kg = 3.5 
mm diameter and infancy above 3.5 kg = 4.0 
mm diameter as well as intra-operative 
vascular assessment. Oral aspirin, 
5mg/kg/day were started immediately on the 
arrival to ICU. No post-operative heparin 
given. Control Chest X-Ray and control 2D-
echocardiography were done while in the ICU 
to exclude haematoma, to determine shunt 
patency, pulmonary artery anatomy and left 
ventricular function.   
Results 
During this study, a total of 20 patients 
studied. Male to female ratio was 1.9:1 and 
55% of all patients belong to infancy age 
group (Table 1). Two patients had pre-
operative ICU admission for stabilization 
prior to MBTS. 
The commonest indication for MBTS was 
Tetralogy of Fallot which accounted for 70% 
of cases. Other indications were pulmonary 
atresia with or without VSD, tricuspid atresia 
with pulmonary atresia or stenosis and DORV 
with pulmonary atresia or stenosis (Table 2). 
Right MBTS accounted for 95% versus 5% 
for left MBTS. Mean duration for ICU stay 
was 2 days, mean duration for mechanical 
ventilation was four and half hours, mean 
hospital stay was 7 days, mean pre-operative 
oxygen saturation was 46% (Std Dev.= 7.20 ) 
and mean post-operative oxygen saturation 
was 84% (Std Dev.= 6.20 ){Table 3}. No 
post-operative bleeding, shunt thrombosis, 
peri-shunt seroma or death occurred in this 
study. 
Table1. To determine the age group per sex  
Age(months)/sex Male Female Total  % 
0-12 9 2 11  55 
13-60 3 5 8  40 
> 61 1 0 1  5 
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Total 13 7 20  100 
Male: Female = 1.9:1 Mean age = 27.4 (SD=28.91)  
 
Table2.  To determine the Indications for MBTS  
 
Table3. To determine the surgical outcome of MBTS 
Surgical outcome Number 
Mean duration of ICU stay(days) 2  (Std= 0.68) 
Mean duration of mechanical ventilation (hours) 4.30 (Std= 3.27) 
Mean duration of Hospital stay (days) 7 (Std=4.88) 
Mean preoperative Oxygen saturation (%) 46 (Std=7.20) 
Mean postoperative Oxygen saturation (%) 84 (Std=6.20) 
Bleeding 0 
Shunt thrombosis 0 




A total of 20 children underwent MBTS. The 
Male: Female ratio was 1.9:1. Their mean age 
on presentation was 27.4 months. Infants 
above one month of age accounted for about 
55% of all children. Two patients had pre-
operative ICU admission for haemodynamic 
and biochemical stabilization prior to MBTS. 
Study by Sivakumar et al5 revealed 10 out of 
20 neonates who underwent MBTS had pre-
operative ICU admission for stabilization 
prior to MBTS. Gladman et al8 performed a 
MBTS in 65 children with a mean age of 58 
days and 95% were done on the right side. 
Majority of patients in this study, 95% 
underwent right MBTS and only 5% done on 
the left side. Right MBTS make shunt ligation 
during definitive surgery easier compared to 
the left side. Left MBTS is mainly indicated 
for small left pulmonary artery anatomy 
compared to the right side. 
The commonest indications for MBTS in this 
study included Tetralogy of Fallot (70%), 
pulmonary atresia with or without VSD 
(10%), tricuspid atresia with pulmonary 
atresia or stenosis (10%) and DORV with 
pulmonary atresia or stenosis (10%). Similar 
findings were obtained by other studies with a 
single ventricle physiology anomaly 
associated with pulmonary atresia in addition 
5,9. 
In this study no patient received post-
operative heparin as an anticoagulant to 
prevent shunt thrombosis except aspirin. No 
shunt failure in terms of shunt thrombosis, 
peri-shunt (graft) seroma or bleeding. No 
patient who underwent thoracotomy for re-
Diagnosis Number 
Tetralogy of Fallot 14 (70%) 
Pulmonary atresia with/without VSD 2 (10%) 
Tricuspid atresia + Pulmonary atresia/stenosis 2 (10%) 
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exploration and no death occurred in this 
study. 
The role of heparin in MBTS has remained 
controversial. Berger et al (6) found heparin 
as an independent risk factor for peri-graft 
seroma following MBTS but other studies 
concluded that heparin has no role post-
operatively. Mullen et al (7) studied on 23 
patients who underwent MBTS using a single 
dose of heparin intra-operatively and no post-
operative heparin given. The findings 
revealed no post-operative bleeding or 
seroma developed, no shunt failure occurred 
during a mean follow-up of 18 months. It was 
concluded that shunt thrombosis is more 
likely related to intra-operative technical 
difficulty or extremely small pulmonary 
artery size. Gladman et al (8) found 
pulmonary artery distortion in about 33% of 
children who underwent MBTS and shunt 
stenosis was common and correlated with a 
younger age at palliation. 
MBTS improve the general condition of the 
patient. Our study revealed a remarkable 
improvement in terms of oxygen saturation, 
duration of mechanical ventilation, ICU and 
hospital stay and mortality. In this study, 
mean oxygen saturation was significantly 
improved from 46% to 84% (x2 =7.03, p = 
0.0080), mean ICU stay was 2 days, mean 
duration of mechanical ventilation was 4 
hours and 30 minutes, and mean hospital stay 
was 7 days post-operatively. Other studies 
had mean oxygen saturation improvement 
from 66% to 77% (4, 5), mean ICU stay of 5 
days (5), peri-graft seroma less than 3% (2, 6, 
8), shunt patency of 80% to 89% (5, 10) and 
mortality from 0 to 15% (4, 5, 10).  
Conclusion   
The commonest indication for MBTS is TOF. 
Intra-operative single dose of heparin 
followed by post-operative oral aspirin as 
anticoagulant regimen was not associated 
with a major complication in terms of 
bleeding, seroma, shunt thrombosis or death.  
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